A $77m deal with creditors to purchase GenCanna as a going concern looks unlikely to be the final step in an ongoing bankruptcy drama surrounding one of the US’s largest hemp processing companies
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields